Artios
Artios is pioneering next-generation approaches in the DNA damage response (DDR) field through its comprehensive anti-cancer approach and the deep experience of its team of DDR drug developers.
Visit websiteCambridge, UK
Healthtech
Funding summary
- Total raised
- €258.2M
- Funding rounds
- 3
Investors in Artios
Investors on record for Artios. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Artios?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors